Skip to content

Comparative analysis of calcium free dialysate and calcium containing dialysate in continuous renal replacement therapy with citrate anticoagulation

Comparative analysis of calcium free dialysate and calcium containing dialysate in continuous renal replacement therapy with citrate anticoagulation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048238
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-05
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:CVVHD mode with calcium-free dialysate
Group 2:CVVHDF mode with calcium-free dialysate
Group 3:CVVHDF mode, using calcium-containing dialysate

Sponsors

Xiamen Cardiovascular Hospital, Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: CRRT treatment indications must be met (one of which is met): severe congestive heart failure, severe acid-base imbalance and electrolyte disturbance, acute kidney injury (AKI) stage 2-3, perioperative prevention of contrast-induced nephropathy , combined with extracorporeal membrane oxygenation (ECMO).

Exclusion criteria

Exclusion criteria: Severe liver dysfunction (Child-Pugh C), refractory hypoxemia (PO22.8mmol/L), hypernatremia (serum sodium>150mmol/L), metabolic alkalosis (HCO3->27mmol/L).

Design outcomes

Primary

MeasureTime frame
blood gas analysis;biochemical detection;coagulation function;routine blood test;arterial pressure, venous pressure, transmembrane pressure of CRRT machine;filter thrombus classification;

Countries

China

Contacts

Public ContactMeng Fanqi

Xiamen Cardiovascular Hospital, Xiamen University

mengfanqi19831001@163.com+86 15959232882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026